Literature DB >> 24743380

A 5-year experience of benign pancreatic hyperenzymemia.

Eleonora Galassi1, Chiara Birtolo, Marina Migliori, Luciana Bastagli, Veronica Gabusi, Vincenzo Stanghellini, Roberto De Giorgio.   

Abstract

OBJECTIVE: Benign pancreatic hyperenzymemia is characterized by a long-term increase of serum pancreatic enzymes in otherwise healthy subjects. This study was designed to determine (a) whether all pancreatic enzymes are elevated, (b) the extent of each enzyme increase, (c) the relative frequency of the familial form, and (d) the relative frequencies of pancreatic and salivary hyperamylasemia and macroamylasemia.
METHODS: Two hundred seven asymptomatic subjects with benign pancreatic hyperenzymemia were studied during the 5-year period. Serum amylase, isoamylase, and lipase levels were assessed by immunoenzymatic assays.
RESULTS: Most (n = 183; 88.4%) patients had benign pancreatic hyperenzymemia; 155 (74.9%) patients had an abnormal increase of all 3 enzymes, 15 (7.2%) patients of only lipase, and 13 (6.3%) patients of only amylase and pancreatic isoamylase. Lipase levels were the highest (1.1-21 times above upper limit). Of the 183 subjects, 72 were members of 35 different families, 15 (7.2%) had increased salivary amylase, and 9 (4.3%) had macroamylasemia. Wide day-to-day fluctuations of pancreatic enzymes, including falls within the reference ranges, were recorded.
CONCLUSIONS: All enzymes were increased in benign pancreatic hyperenzymemia, with lipase showing the highest elevation. Doctors should reassure patients about the benign nature of this condition and limit repeating useless examinations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24743380     DOI: 10.1097/MPA.0000000000000138

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  4 in total

1.  Man with epigastric pain and persistently elevated serum lipase.

Authors:  Caroline Annette Erika Bachmeier; Adam Morton
Journal:  BMJ Case Rep       Date:  2019-04-16

2.  Letter to the editor.

Authors:  Joerg M Steiner; Panagiotis Xenoulis; Jan S Suchodolski
Journal:  J Vet Intern Med       Date:  2014 Nov-Dec       Impact factor: 3.333

3.  Hyperamylasemia Related to Sertraline.

Authors:  Mehmet Emin Ceylan; Alper Evrensel; Barış Önen Ünsalver
Journal:  Korean J Fam Med       Date:  2016-07-21

Review 4.  Secretin-stimulated MR cholangiopancreatography: spectrum of findings in pancreatic diseases.

Authors:  Piero Boraschi; Francescamaria Donati; Rosa Cervelli; Federica Pacciardi
Journal:  Insights Imaging       Date:  2016-09-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.